A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

NCT05650060 ·Status: COMPLETED

Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis

NCT05478499 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

NCT06042920 ·Status: TERMINATED ·Phase: PHASE4

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

NCT01782664 ·Status: COMPLETED ·Phase: PHASE2

An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate-to-Severe Psoriasis

NCT03924427 ·Status: COMPLETED ·Phase: PHASE3

Open-label Study of Subcutaneous Secukinumab to Evaluate Efficacy and Safety in Patients With Plaque Psoriasis Who Had Inadequate Response to Cyclosporine A

NCT02547714 ·Status: COMPLETED ·Phase: PHASE4

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

NCT02362789 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

NCT02776033 ·Status: COMPLETED ·Phase: PHASE2

A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

NCT05744466 ·Status: RECRUITING

Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

NCT06258668 ·Status: RECRUITING

A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Moderate to Severe Plaque Psoriasis

NCT04772079 ·Status: RECRUITING ·Phase: PHASE3

Evaluation of Cardiovascular Risk Markers in Psoriasis Patients Treated With Secukinumab

NCT02559622 ·Status: COMPLETED ·Phase: PHASE3

Study of Efficacy and Safety of Secukinumab in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis

NCT03066609 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis

NCT01412944 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

NCT02618759 ·Status: COMPLETED ·Phase: PHASE3

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

NCT07116967 ·Status: RECRUITING ·Phase: PHASE3

Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment

NCT06666114 ·Status: COMPLETED

Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy, Safety and Tolerability of Secukinumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT01952015 ·Status: COMPLETED ·Phase: PHASE3

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

NCT02826603 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque Psoriasis

NCT05600036 ·Status: COMPLETED ·Phase: PHASE2

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

NCT03055494 ·Status: COMPLETED ·Phase: PHASE4

Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry

NCT06172426 ·Status: COMPLETED